Company intelligence / Profile preview

Vira Health

London, England, United Kingdomvira.health ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Vira Health’s Stella platform has reached over two million people since launch. The company provides evidence-based digital therapeutics and telemedicine for menopause symptom management. Clinical results focus on improved quality of life outcomes through personalized behavioral interventions and access to pharmaceutical therapies when appropriate. No traditional clinical trial data as would be expected from a biotech/pharma.

Therapeutic areas: EndocrinologyCardiovascularNeurologyWomen's Health
Modalities: Non-pharmacological therapySmall moleculeDevice
Industry: Non-Academic Healthcare

Drug pipeline

1 asset

Stella

Commercial

Indications: Menopause

Partnerships

Kaia Health – partnership to deliver pelvic floor therapy alongside menopause support

Beyond the preview

Go deeper on Vira Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vira Health.

Explore the full profile